The Adult Vaccine Access Coalition has come together to raise awareness, improve access, and increase utilization of vaccines among adults.
To help us advocate to policymakers why adult vaccine access is important, we want to hear your stories!
Supporting and advocating for investments and policies to track adult immunization status and improve patient outcomes.
Measuring progress towards benchmarks to improve preventive care.
Increasing access to, and utilization of, vaccines among at risk populations to prevent illness.
AVAC Letter to Majority Leader McConnell and Chairmen Hatch, Alexander, and Enzi about AHCA
June 12, 2017 The Honorable Mitch McConnell Majority Leader United States Senate S-230 U.S. Capitol Building Washington, DC 20510 The Honorable Orrin Hatch Chairman Senate Finance Committee 219 Dirksen Senate Office Building Washington, DC 20510 The Honorable Lamar Alexander Chairman Senate HELP Committee 428 Dirksen Senate Office Building Washington, DC 20510 The Honorable Michael Enzi Chairman Senate Budget Committee 624 ...
2018 Medicare Advantage and Part D Advance Notice and Final Call Letter
To Whom It May Concern: As participants in the Adult Vaccine Access Coalition (AVAC), we appreciate the opportunity to comment on the Centers for Medicare and Medicaid Services (CMS) 2018 Medicare Advantage and Part D Advance Notice and Final Call Letter. Specifically: • Pneumococcal Vaccination Status for Older Adults (p. 98): AVAC encourages CMS to continue to work with NCQA, ...
RE: Proposed Changes to Existing Measure for HEDIS 2017: Pneumococcal Vaccination Status for Older Adults (PNU)
As participants in the Adult Vaccine Access Coalition (AVAC), we appreciate the opportunity to comment on the National Committee for Quality Assurance (NCQA) Proposed New Measure for HEDIS®1 2018: Pneumococcal Vaccination Status for Older Adults (PVS) included in its update to guidelines and measures using electronic clinical data systems (ECDS). We are pleased to offer our support for this measure. ...
Fact Sheet: Health and Economic Benefits of Adult Immunizations
As recently as the mid-20th century, conditions such as polio, measles, rubella and diphtheria were still common, striking thousands ill and taking the lives of hundreds more. The development of safe and effective vaccines has revolutionized medicine and turned once prevalent conditions into mostly a distant memory. The key to maintaining and building on these advances is constant vigilance. Continued ...
Fact Sheet: Financial Barriers to Adult Immunization
Immunizations are a cornerstone of our nation’s disease prevention efforts and have demonstrated a long track record of success as a cost-effective means of reducing disease burden and saving lives. This fact sheet provides information on what Congress and the Administration can do to reduce financial barriers to adult immunization and improve adult vaccination rates. Despite the well-known benefits of ...
Op-ed Making Vaccine-Preventable Diseases History
Polio. Smallpox. Rubella. Diphtheria. For the vast majority of Americans living today, the closest we’ve ever come into contact with those diseases is when we bring up their respective Wikipedia pages. And yet as recently as the mid-20th century, they were still quite common. What’s changed between then and now? Simple: vaccines. One of the greatest public health achievements of the 20th century, particularly ...